German pharmaceutical company BioNotech said on Tuesday that its vaccine to protect against the corona virus is also effective against the new form. But, if needed, the company can develop a new vaccine in six weeks. The company’s co-founder Ugur Saheen said, “From a scientific perspective, there is every possibility that the vaccine will also be effective on the new type of the virus.”
It is noteworthy that after the discovery of the new form of corona virus in the UK and London in the UK in recent weeks, worries have increased in the world. However, so far there have been no indications that this redesign is more deadly but many countries in Europe and outside have banned travel from Britain. Meanwhile, the European Union has approved the Pfizer-BioNotech vaccine.
Bioentech Chief Executive Officer (CEO) Ugur Saheen said in a press conference on Tuesday, “At this time we only know whether our vaccine is capable of providing protection against the new form.” He said, “But based on scientific facts But it is very likely that this vaccine will also work to prepare immunity against the new form of the virus.
Saheen said that protein fractions on the new form of the virus in the UK are up to 99 percent similar to the current strain, so on scientific grounds Bioentech is confident that the vaccine will remain effective. Saheen said, “Scientists are currently testing it and data will be available in the next two weeks. He said, ‘Hopefully our vaccine will work.’
Saheen said that the vaccine will be prepared to fight the new form of the virus and it may take six weeks. However, prior to its use, regulatory approval will be required. Explain that BioNotech has prepared a vaccine against corona virus in association with Pfizer, the leading pharmaceutical company of America.